Studying polymorphic variants of the NAT2 gene (NAT2*5 and NAT2*7) in Nenets populations of Northern Siberia

被引:8
|
作者
Tiis, Roza Pavlovna [1 ,2 ]
Osipova, Ludmila Pavlovna [1 ,2 ]
Lichman, Daria Veniaminovna [1 ,2 ]
Voronina, Elena Nikolaevna [2 ,3 ]
Filipenko, Maxim Leonidovich [2 ,3 ]
机构
[1] RAS, Inst Cytol & Genet, SB, Novosibirsk 630090, Russia
[2] Novosibirsk State Univ, Novosibirsk 630090, Russia
[3] RAS, Inst Chem Biol & Fundamental Med, SB, Novosibirsk, Russia
基金
俄罗斯科学基金会;
关键词
Xenobiotics; NAT2; gene; NAT2*5; rs1801280; NAT2*7; rs1799931; Forest and Tundra Nenets; Northern Siberia; ARYLAMINE N-ACETYLTRANSFERASES; DRUG-METABOLIZING-ENZYMES; LUNG-CANCER; BLADDER-CANCER; RISK; N-ACETYLTRANSFERASE-2; GSTM1; SUSCEPTIBILITY; ACETYLATION; GENOTYPE;
D O I
10.1186/s12863-020-00909-4
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background N-acetyltransferase 2 plays a crucial role in the metabolism of a wide range of xenobiotics, including many drugs, carcinogens, and other chemicals in the human environment. The article presents for the first time data on the frequency of two important "slow" variants of NAT2 gene (NAT2*5, rs1801280 and NAT2*7, rs1799931), which significantly affect the rate of xenobiotics acetylation, among representatives of indigenous populations of Forest and Tundra Nenets in Northern Siberia. The aim of this study was to identify the frequencies of these variants and compare them with frequencies in other ethnic populations. Results NAT2*5 (T341C) genotyping revealed frequencies of 28,0% and 38,6% for Tundra and Forest Nenets, respectively. The frequencies of NAT2*7 (G857A) variant were 9,8% and 8,2% for Tundra and Forest Nenets, respectively. Polymorphic variants frequencies for Nenets are intermediate between those in populations of Europeans and Asians. These results can probably be explained by the presence of both European and Asian components in Nenets gene pools. Conclusions The results of this study expand the knowledge of NAT2 polymorphism in world populations. These data may also help assess the genetic predisposition of Nenets to multifactorial diseases associated with polymorphism in the NAT2 gene and, in general, contribute to the development of personalized medicine in reference to native people of Siberia.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] NAT2 and Bladder Cancer-Response
    Pesch, Beate
    Bruening, Thomas
    Vineis, Paolo
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2014, 23 (03) : 562 - 562
  • [22] NAT2 and Bladder Cancer-Letter
    Golka, Klaus
    Blaszkewicz, Meinolf
    Selinski, Silvia
    Hengstler, Jan G.
    Bolt, Hermann M.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2014, 23 (03) : 561 - 561
  • [23] Genotyping and phenotyping, using NAT2 as an example
    Golka, K
    Blaszkewicz, M
    BIOLOGICAL MONITORING: PROSPECTD IN OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2002, : 96 - 102
  • [24] Unraveling ambiguous NAT2 genotyping data
    Agundez, Jose A. G.
    Golka, Klaus
    Martinez, Carmen
    Selinski, Silvia
    Blaszkewicz, Meinolf
    Garcia-Martin, Elena
    CLINICAL CHEMISTRY, 2008, 54 (08) : 1390 - 1394
  • [25] NAT2*5C(T341C),NAT2*5A(C481T),NAT2*6B(G590A) variants and the risk of sporadic colon cancer: A Romanian study
    Procopciuc, L.
    Osian, G.
    Olteanu, I
    Viad, L.
    ANNALS OF ONCOLOGY, 2008, 19 : 88 - 88
  • [26] NAT2 genetic variations among South Indian populations
    Lakkakula S.
    Pathapati R.M.
    Chaubey G.
    Munirajan A.K.
    Lakkakula B.V.K.S.
    Maram R.
    Human Genome Variation, 1 (1)
  • [27] NAT2 and NQO1 variants and risk for RCC
    Semenza, JC
    Ziogas, A
    Largent, J
    Peel, D
    Anton-Culver, H
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 37 (04) : A30 - A30
  • [28] Pharmacokinetics of isoniazid in relation to NAT2 genotypes
    Cao, Xiaomei
    Li, Jinheng
    Chen, Bing
    Leng, Weiwei
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 211 - 211
  • [29] Reconstruction of NAT2 haplotypes in a Spanish cohort
    Agundez, Jose A. G.
    Golka, Klaus
    Martinez, Carmen
    Selinski, Silvia
    Blaszkewicz, Meinolf
    Garcia-Martin, Elena
    TOXICOLOGY LETTERS, 2009, 189 : S108 - S108
  • [30] A pilot study to investigate the utility of NAT2 genotype-guided isoniazid monotherapy regimens in NAT2 slow acetylators
    Yoo, Hyounggyoon
    Ji, Sang Chun
    Cho, Joo-Youn
    Kim, Sang-Heon
    Yoon, Jihoon G.
    Lee, Min Goo
    Yu, Kyung-Sang
    Jang, In-Jin
    Oh, Jaeseong
    PHARMACOGENETICS AND GENOMICS, 2021, 31 (03): : 68 - 73